Mumbai, India , is rapidly emerging as a significant hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several organizations have established robust manufacturing facilities focusing on this important antiviral drug . Identifying the absolute top manufacturers can be difficult du